Bioprocess Engineering
Bioprocess Engineering combines biotechnology and designing for the purpose of creation of materials from inexhaustible feedstock. This field includes basic bio atomic assessment on proteins, compounds and organisms, moreover as work on biosensors and bioreactors. Applications that hold food life cycle and conservation; drug, nutraceutical and sugar creation; air and waste material treatment; bio-based underlying themes for above sub-atomic structures; microfluidics for bioreactors and DNA chips; bioenergy; and applications inside the mash and paper firm. The square measure normally connects to medication applications, which is likely to tranquilize digestion, tissue designing and bio-based helpful medicines. The option U.S compound end-use item market is relied upon to increasing from $149.9 billion out of 2016 to an expected $345.6 billion by the end of 2021.
Related Conference of Bioprocess Engineering
Bioprocess Engineering Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Advances in Separation Techniques - ANALYTICA ACTA 2024 (France)
- Analytical Chemistry and Methodology - ANALYTICA ACTA 2024 (France)
- Analytical Technique for Clinical Chemistry - ANALYTICA ACTA 2024 (France)
- Analytical Technique for Thermal analysis - ANALYTICA ACTA 2024 (France)
- Bioanalytical Methodology - ANALYTICA ACTA 2024 (France)
- Biochemistry - ANALYTICA ACTA 2024 (France)
- Biomarkers & Next-Generation Sequencing - Biomarkers 2024 (UK)
- Biomarkers based on epidemiological investigations - Biomarkers 2024 (UK)
- Biomarkers for Cancer Diagnosis - Biomarkers 2024 (UK)
- Biomarkers for Early Diagnosis and Prognosis - Biomarkers 2024 (UK)
- Biomarkers for non-cancerous diseases - Biomarkers 2024 (UK)
- Biomarkers in Diagnosis: Challenges and Approaches - Biomarkers 2024 (UK)
- Biomarkers in Disease Treatment - Biomarkers 2024 (UK)
- Biomarkers in Drug discovery and development - Biomarkers 2024 (UK)
- Biomarkers in Immune-Oncology - Biomarkers 2024 (UK)
- Biomarkers of Cardiovascular disorders - Biomarkers 2024 (UK)
- Biomarkers of Disorders of the Nervous System - Biomarkers 2024 (UK)
- Biomarkers: Validation & Verification - Biomarkers 2024 (UK)
- Biopolymers and Biomaterials - ANALYTICA ACTA 2024 (France)
- Chromatography - ANALYTICA ACTA 2024 (France)
- Clinical and Biomedical Engineering - Biomarkers 2024 (UK)
- Clinical Diagnostics Equipment and Kits - ANALYTICA ACTA 2024 (France)
- Clinical Research & Biomarkers - Biomarkers 2024 (UK)
- Discovery of new biomarkers/validation/technologies - Biomarkers 2024 (UK)
- Electrophoresis - ANALYTICA ACTA 2024 (France)
- Entrepreneur Investments Meet - Biomarkers 2024 (UK)
- Environmental Analytical Chemistry - ANALYTICA ACTA 2024 (France)
- Genomic Biomarkers in Clinical Development - Biomarkers 2024 (UK)
- Hyphenated Techniques - ANALYTICA ACTA 2024 (France)
- Imaging Technologies and Diagnostic tests of Biomarkers - Biomarkers 2024 (UK)
- Innovation in Food Analysis & Testing - ANALYTICA ACTA 2024 (France)
- Mass Spectrometry - ANALYTICA ACTA 2024 (France)
- Method development and validation - ANALYTICA ACTA 2024 (France)
- Microscopy - ANALYTICA ACTA 2024 (France)
- New Instrumentation and Equipment - ANALYTICA ACTA 2024 (France)
- Novel Optical Sensors and Biosensors - ANALYTICA ACTA 2024 (France)
- Pharmaceutical Analytics - ANALYTICA ACTA 2024 (France)
- Polymer Science and Material Science - ANALYTICA ACTA 2024 (France)
- Proteomics and its applications - ANALYTICA ACTA 2024 (France)
- Regulatory Issues and Biosafety Challenges in Bioanalysis - ANALYTICA ACTA 2024 (France)
- Regulatory issues and Biosafety challenges in bioanalysis - ANALYTICA ACTA 2024 (France)
- Spectroscopy - ANALYTICA ACTA 2024 (France)